White House Denies Trump Using Obesity Drug in Compassionate Use Program
June 23, 2026·about 3 hours ago·via Newsweek

The White House has flatly denied reports that former President Trump accessed an obesity medication through the FDA's Compassionate Use Program. This story matters because it touches on questions about equal access to experimental treatments and whether political figures receive special treatment unavailable to ordinary Americans. The denial comes as these weight-loss drugs remain in high demand but limited supply for everyday citizens. Read more about this...